Literature DB >> 22554695

Extended nasolabial flap compared with the platysma myocutaneous muscle flap for reconstruction of intraoral defects after release of oral submucous fibrosis: a comparative study.

Chandrashekhar R Bande1, Abhay Datarkar, Neeraj Khare.   

Abstract

We compared extended nasolabial flaps and coronoidectomy with platysma myocutaneous muscle flaps in the management of 20 randomly selected patients with histologically confirmed oral submucous fibrosis. Ten patients were treated by release of fibrous bands, bilateral coronoidectomy, and reconstruction with an extended nasolabial flap (nasolabial group), and the other 10 by bilateral release of fibrous bands, coronoidectomy, and reconstruction with a platysma myocutaneous muscle flap (platysma group). In the nasolabial group the mean preoperative interincisal mouth opening was 12(range 3-14)mm, and in the platysma group it was 11 (3-13). All 20 patients were given vigorous postoperative physiotherapy, and were followed up for 3 years. The interincisal mouth opening improved to 47(35-45)mm in the nasolabial group and 48(41-52)mm in the platysma group. The procedures were equally effective in the management of the oral submucous fibrosis, except that the extraoral scar was not aesthetically acceptable in the nasolabial group.
Copyright © 2012 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22554695     DOI: 10.1016/j.bjoms.2012.02.015

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  13 in total

1.  Treatment of oral submucous fibrosis using split skin graft and a polyethylene stent: a prospective study.

Authors:  Chen Loong Soh; M R Muthusekhar
Journal:  J Maxillofac Oral Surg       Date:  2014-08-13

2.  Utility of superiorly based platysma myocutaneous flap for reconstruction of intraoral surgical defects: our experience.

Authors:  Chandrashekhar Bande; Ajit Joshi; Mayur Gawande; Manish Tiwari; Vijay Rode
Journal:  Oral Maxillofac Surg       Date:  2017-11-23

3.  Efficacy of Prednisolone Mouthwash in Management of Grade III Oral Submucous Fibrosis: A Newer Drug Regimen.

Authors:  Abhay Datarkar; Abhishek Akare; Shikha Tayal
Journal:  J Maxillofac Oral Surg       Date:  2019-05-28

Review 4.  What is the Optimal Reconstructive Option for Oral Submucous Fibrosis? A Systematic Review and Meta-analysis of Buccal Pad of Fat Versus Conventional Nasolabial and Extended Nasolabial Flap Versus Platysma Myocutaneous Flap.

Authors:  Preeti Tiwari; Rathindra Nath Bera; Nishtha Chauhan
Journal:  J Maxillofac Oral Surg       Date:  2020-05-05

Review 5.  Complications of platysma myocutaneous flap in patients with oral submucosal fibrosis: A systematic review.

Authors:  Uma Shanker Pal; Harshita Maurya; Roop Ganguly; R K Singh; Vijay Kumar
Journal:  J Oral Biol Craniofac Res       Date:  2022-05-21

6.  Lateral Oropharyngeal Wall Coverage with Buccinator Myomucosal and Buccal Fat Pad Flaps.

Authors:  Bok Ki Jung; Seung Yong Song; Se-Heon Kim; Young Seok Kim; Won Jai Lee; Jong Won Hong; Tai Suk Roh; Dae Hyun Lew
Journal:  Arch Plast Surg       Date:  2015-07-14

7.  Immediate versus delayed aggressive physical therapy following buccal fat pad interposition in oral submucous fibrosis-a prospective study in Central India.

Authors:  Chandrashekhar Bande; Pawan Dawane; M K Gupta; Mayur Gawande; Vijay Rode
Journal:  Oral Maxillofac Surg       Date:  2016-09-28

Review 8.  The place of nasolabial flap in orofacial reconstruction: A review.

Authors:  Amin Rahpeyma; Saeedeh Khajehahmadi
Journal:  Ann Med Surg (Lond)       Date:  2016-11-23

9.  Effectiveness of Long Term Supervised and Assisted Physiotherapy in Postsurgery Oral Submucous Fibrosis Patients.

Authors:  S Kale; N Srivastava; V Bagga; A Shetty
Journal:  Case Rep Dent       Date:  2016-11-03

10.  Nasolabial Flap in Maxillofacial Gunshot Trauma: A Case Series.

Authors:  Amin Rahpeyma; Saeedeh Khajehahmadi
Journal:  Arch Trauma Res       Date:  2016-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.